Is Roche/RHHBY an under-performing stock? Is Agilent overpriced?

Agilent Technologies, Inc. (NYSE:A)

NYSE:A Agilent Technologies, Inc.

these four are signficant players in the genome sequencing market, but RHHB stock price hasn't take off in the same way, and Agilent is way out in front.

Does this make RHHB a good buy, or, is there something wrong, and making the others a better prospect? Is Agilent a sell?

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。